Despite these compelling findings, our study has certain limitations: First, we did not comprehensively evaluate NLRP5’s impact on tumor-infiltrating immune cells, such as macrophages and CD8+ T cells, which are crucial components of the tumor microenvironment. The gene discussed is NLRP5; the disease is neoplasm.